Emerging concepts in the pathophysiology of type 2 diabetes mellitus
- PMID: 19421965
- DOI: 10.1002/msj.20113
Emerging concepts in the pathophysiology of type 2 diabetes mellitus
Abstract
Type 2 diabetes mellitus is a multifactorial metabolic disorder. It is characterized by chronic hyperglycemia, insulin resistance, and a relative insulin secretion defect. The prevalence of type 2 diabetes mellitus has risen worldwide in large part because of an increase in obesity and sedentary lifestyles. The underlying pathophysiology and complications of type 2 diabetes mellitus are still being elucidated. Recent advances in diabetes research have helped us to gain a better understanding about insulin resistance and insulin secretion defects. The evolving understanding about the influence of the incretin effect, insulin signal transduction, adipose tissue, intra-islet cell communication, and inflammation is changing the way in which we view type 2 diabetes mellitus. This new understanding will eventually provide us with new treatment approaches to help patients who have type 2 diabetes mellitus. This article gives a review of the current and emerging concepts of the pathophysiology of type 2 diabetes mellitus.
(c) 2009 Mount Sinai School of Medicine.
Similar articles
-
Fate of the beta-cell in the pathophysiology of type 2 diabetes.J Am Pharm Assoc (2003). 2009 Sep-Oct;49 Suppl 1:S10-5. doi: 10.1331/JAPhA.2009.09076. J Am Pharm Assoc (2003). 2009. PMID: 19801360 Review.
-
The required beta cell research for improving treatment of type 2 diabetes.J Intern Med. 2013 Sep;274(3):203-14. doi: 10.1111/joim.12096. Epub 2013 Jun 21. J Intern Med. 2013. PMID: 23751050 Review.
-
Improved glycemic control enhances the incretin effect in patients with type 2 diabetes.J Clin Endocrinol Metab. 2013 Dec;98(12):4702-8. doi: 10.1210/jc.2013-1199. Epub 2013 Oct 3. J Clin Endocrinol Metab. 2013. PMID: 24092826
-
Type II diabetes mellitus.Adv Intern Med. 1998;43:449-500. Adv Intern Med. 1998. PMID: 9506190 Review.
-
Pathophysiology of type 2 diabetes: targeting islet cell dysfunction.J Am Osteopath Assoc. 2010 Mar;110(3 Suppl 2):S2-7. J Am Osteopath Assoc. 2010. PMID: 20382838 Review.
Cited by
-
Relationship between salivary levels of interleukin-8 and HbA1c in patients with type 2 diabetes.Endocrinol Diabetes Metab. 2023 Nov;6(6):e455. doi: 10.1002/edm2.455. Epub 2023 Sep 29. Endocrinol Diabetes Metab. 2023. PMID: 37775939 Free PMC article.
-
The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications.J Physiol Biochem. 2022 May;78(2):307-322. doi: 10.1007/s13105-021-00860-7. Epub 2022 Jan 6. J Physiol Biochem. 2022. PMID: 34988903 Review.
-
Assessment of Salivary Adipokines Resistin, Visfatin, and Ghrelin as Type 2 Diabetes Mellitus Biomarkers.Biochem Res Int. 2018 Feb 1;2018:7463796. doi: 10.1155/2018/7463796. eCollection 2018. Biochem Res Int. 2018. PMID: 29487749 Free PMC article.
-
Variants at the endocannabinoid receptor CB1 gene (CNR1) and insulin sensitivity, type 2 diabetes, and coronary heart disease.Obesity (Silver Spring). 2011 Oct;19(10):2031-7. doi: 10.1038/oby.2011.135. Epub 2011 Jun 2. Obesity (Silver Spring). 2011. PMID: 21633404 Free PMC article.
-
Integrating Network Pharmacology and Molecular Docking Approaches to Decipher the Multi-Target Pharmacological Mechanism of Abrus precatorius L. Acting on Diabetes.Pharmaceuticals (Basel). 2022 Mar 29;15(4):414. doi: 10.3390/ph15040414. Pharmaceuticals (Basel). 2022. PMID: 35455411 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical